calculation of cutoff time point in case of multiphasic modified release [NCA / SHAM]

posted by Biostats – India, 2017-11-25 09:22 (987 d 04:13 ago) – Posting: # 18004
Views: 2,465

Dear all,

As per EMA guideline on the pharmacokinetic and clinical evaluation of modified release dosage forms in section 6.8.1.1 single dose studies

“For multiphasic modified release products additional parameters to be determined include partialAUC, Cmax and tmax in all phases. The time point for truncating the partialAUC should be based on the PK profile for the e.g. IR and the MR parts respectively and should be justified and pre-specified in the study protocol.”

Is there any scientific method or formula to calculate the time point for truncating the partial AUC (cutoff time point)?


Edit: Category changed; see also this post #1. [Helmut]

Complete thread:

Activity
 Admin contact
20,982 posts in 4,374 threads, 1,460 registered users;
online 37 (0 registered, 37 guests [including 24 identified bots]).
Forum time: Saturday 14:35 CEST (Europe/Vienna)

Patients may recover in spite of drugs or because of them.    John Gaddum

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5